A Agilent Technologies, Inc. Common Stock
حول Agilent Technologies, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
اقرأ المزيد
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
From 1999 to 2014, the company produced optics (LED, laser), semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.
History
In 1965, Hewlett-Packard branched out into scientific equipment by acquiring F&M Scientific, maker of gas chromatographs. Agilent Technologies was created in 1999 as a spin-off of several business units of Hewlett-Packard including test & measurement, optics, instrumentation and chemical analysis, electronic components, and medical equipment product lines. The split was predicated on the difficulty of growing HP's revenue stream and on the competitive vigor of smaller, more agile competitors.
The company's launch slogan was "Innovating the HP Way", which capitalized on the strong HP corporate culture called The HP Way. The starburst logo was selected to reflect "a burst of insight" (or "spark of insight") and the name "Agilent" aimed to invoke the notion of agility as a trait of the new firm. The Agilent spin-off was accompanied by an initial public offering which raised $2.1 billion, setting a record at the time.
2000–2009
In the early 2000s, "economic uncertainty" depressed demand for Agilent's products, including slow sales of health care products to hospitals in the United States, which accounted for 60% of the company's revenue at the time. The downturn also struck sales in the communications and semiconductor markets, where orders amounting to $500 million were canceled by buyers. These poor economic conditions prompted large reductions in force with 18,500 positions cut in 2003.
In 2001, in midst of this downsizing, Agilent sold its health care and medical products organization to Philips Medical Systems, and was noted as having a valuation of about $11 billion. HP Medical Products had been the second oldest part of Hewlett-Packard, acquired in the 1950s.
In August 2005, Agilent announced the sale of its business which produced semiconductor integrated circuits (known as "chips") for consumer and industrial uses to Kohlberg Kravis Roberts and Silver Lake Partners for $2.66 billion. This move would involve termination of about 1,300 of the company's 28,000 employees. The group operated as a private company, Avago Technologies, until August 2009, when it was brought public in an IPO. After purchasing Broadcom Corporation in 2016, Avago changed its name to Broadcom Limited.
Also in August 2005, Agilent sold its 47% stake in the light-emitting diode manufacturer Lumileds to Philips for $1 billion. Lumileds originally started as Hewlett-Packard's optoelectronics division. Also in August 2005, Agilent announced a plan to divest its semiconductor test business, composed of both the system-on-chip and memory test market areas. Agilent listed the new company as Verigy on the Nasdaq in mid-2006.
2010 onwards
In 2009, Agilent announced the closure of a subsection of its Test & Measurement division. The product lines affected included the automated optical inspection, solder paste inspection, and automated X-ray products [5DX] in 2004. In 2011, the company, along with the University of California, Davis, announced that it would be establishing the "Davis Millimeter Wave Research Center". Agilent announced it would increase its life sciences engagement through the acquisition of Halo Genomics, based in Uppsala, Sweden, which was involved in next-generation sequencing technology development. On May 17, 2012, Agilent agreed to buy Dako, a Danish cancer diagnostics company, for $2.2 billion, to expand its presence in the life sciences industry.
On September 19, 2013, Agilent announced its decision to separate into two publicly traded companies: Agilent, a life sciences, diagnostics, and applied markets company, and Keysight, an electronic measurement company. The life sciences company retained the Agilent name and the electronic measurement company was called Keysight Technologies. On October 14, 2014, the company announced that it is exiting its Nuclear Magnetic Resonance business. On November 1, the formal separation of Agilent and Keysight Technologies was completed. Agilent announced it had completed the spin-off of its electronic measurement business, Keysight Technologies.
In September 2015, the company announced it would acquire Seahorse Bioscience for $235 million. On July 7, 2016, Agilent announced that it had acquired U.K. based Cobalt Light Systems, which develops and manufactures Raman spectroscopy instruments, for £40 million in cash. In December the company acquired Multiplicom N.V.
In January 2018, the company announced it would acquire Luxcel Biosciences, increasing the company's cell analysis portfolio. In May, Agilent acquired Lasergen, Inc. after the end of its two-year option on a prior investment. In the same month it acquired digital laboratory management company, Genohm, Ultra Scientific, provider of chemical standards and reference materials and Advanced Analytical Technologies, Inc. (AATI), provider of capillary electrophoresis-based molecules for $250 million in cash.
In August the company announced it would acquire glycan reagent producer, ProZyme, Inc. and South Korean instrument distributor, Young In Scientific Co. Ltd. In September Agilent acquired ACEA Biosciences for $250 million increasing the company's presence in cell analysis technologies. In August 2019, Agilent acquired US-based BioTek Instruments, a designer, manufacturer, and distributor of life science instrumentation, for $1.165 billion. On May 1, 2024, Padraig McDonnell succeeded Mike McMullen as CEO.
Products and services
Agilent serves analytical laboratories and the clinical and routine diagnostics markets with a full suite of technology platforms. These include: automation, bioreagents, FISH probes, gas and liquid chromatography, immunohistochemistry, informatics, mass spectrometry, microarrays, spectroscopy, target enrichment, and vacuum technologies.
Agilent also provides lab management services, including enterprise asset management, laboratory business intelligence, equipment management and service, software maintenance, regulatory compliance, sample preparation, genomics and cloning, GC and HPLC columns, spectrometry and spectroscopy supplies, and consumables. The company is known for investing in R&D within its own research labs and those of leading universities to advance the state of knowledge in the life sciences, diagnostics, and chemical analysis space.
In recent years, the company has advanced digital lab instrumentation and technology that improves lab workflow and overall efficiency and productivity. In 2020, Agilent introduced CrossLab Virtual Assist, a mobile app that facilities high-quality remote technical support. Agilent's digital advancements, including CrossLab Connect, have also improved lab optimization and sustainability by providing more efficient utilization of instruments, which can lower a lab's energy consumption.
Agilent is also a pioneer of the target enrichment used as part of a NGS workflow. The portfolio also includes sample prep, QA/QC instrumentation, 2100 bioanalyzers, and automation tools. In early 2023, the company announced a $725 million expansion of its nucleic acid-based therapeutics manufacturing facility in Frederick, Colorado.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
A لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
A مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
| تاريخ الاستحقاق | المبلغ |
|---|---|
| 30 يونيو، 2026 | $0,2550 |
| 31 مارس، 2026 | $0,2550 |
| 6 يناير، 2026 | $0,2550 |
| 30 سبتمبر، 2025 | $0,2480 |
| 1 يوليو، 2025 | $0,2480 |
| 1 إبريل، 2025 | $0,2480 |
| 31 ديسمبر، 2024 | $0,2480 |
| 1 أكتوبر، 2024 | $0,2360 |
| 2 يوليو، 2024 | $0,2360 |
| 1 إبريل، 2024 | $0,2360 |
| 29 ديسمبر، 2023 | $0,2360 |
| 2 أكتوبر، 2023 | $0,2250 |
| 30 يونيو، 2023 | $0,2250 |
| 3 إبريل، 2023 | $0,2250 |
| 30 ديسمبر، 2022 | $0,2250 |
| 3 أكتوبر، 2022 | $0,2100 |
| 1 يوليو، 2022 | $0,2100 |
| 4 إبريل، 2022 | $0,2100 |
| 3 يناير، 2022 | $0,2100 |
| 4 أكتوبر، 2021 | $0,1940 |
A توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 8 27,6%
- شراء 14 48,3%
- احتفاظ 7 24,1%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
19 محللين · 2026-08-19سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $1.49 | $1.44 | 0.05% |
| 31 مارس، 2026 | $1.36 | $1.40 | -0.04% |
| 31 ديسمبر، 2025 | $1.59 | $1.62 | -0.03% |
| 30 سبتمبر، 2025 | $1.37 | $1.39 | -0.02% |
| 30 يونيو، 2025 | $1.31 | $1.29 | 0.02% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | · | $4.47B | $4.20B | $4.04B | |
| Cost of Revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B | $2.50B | $2.36B | · | $2.07B | $2.00B | $2.00B | |
| R&D Expense | $455M | $479M | $481M | $467M | $441M | $495M | $404M | · | $341M | $329M | $330M | |
| SG&A Expense | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B | $1.50B | $1.46B | · | $1.25B | $1.25B | $1.19B | |
| Operating Expenses | $5.47B | $5.02B | $5.48B | $5.23B | $4.97B | $4.49B | $4.22B | · | $3.67B | $3.59B | $3.52B | |
| Operating Income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B | $846M | $941M | · | $807M | $615M | $522M | |
| Interest Expense | $112M | $96M | $95M | $84M | $81M | $78M | $74M | · | $79M | $72M | $66M | |
| Interest Income | $62M | $80M | $51M | $9M | $2M | $8M | $36M | · | $22M | $11M | $7M | |
| Other Non-op | $6M | $49M | $33M | $-39M | $92M | $66M | $16M | · | $53M | $-10M | $17M | |
| Pretax Income | $1.44B | $1.52B | $1.34B | $1.50B | $1.36B | $842M | $919M | · | $803M | $544M | $767M | |
| Income Tax | $132M | $232M | $99M | $250M | $150M | $123M | $-152M | · | $119M | $82M | $42M | |
| Net Income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719M | $1.07B | · | $684M | $462M | $401M | |
| EPS (Basic) | $4.59 | $4.44 | $4.22 | $4.19 | $3.98 | $2.33 | $3.41 | · | $2.12 | $1.42 | $1.20 | |
| EPS (Diluted) | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | · | $2.10 | $1.40 | $1.20 | |
| Shares (Basic) | 284,000,000 | 290,000,000 | 294,000,000 | 299,000,000 | 304,000,000 | 309,000,000 | 314,000,000 | · | 322,000,000 | 326,000,000 | 333,000,000 | |
| Shares (Diluted) | 285,000,000 | 291,000,000 | 296,000,000 | 300,000,000 | 307,000,000 | 312,000,000 | 318,000,000 | · | 326,000,000 | 329,000,000 | 335,000,000 | |
| EBITDA | $1.77B | $1.75B | $1.62B | $1.94B | $1.67B | $1.15B | $1.18B | · | $1.05B | $861M | $775M |
الميزانية العمومية 29
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.79B | $1.33B | $1.59B | $1.05B | $1.48B | $1.44B | $1.38B | $2.25B | $2.68B | $2.29B | $2.00B | |
| Receivables | $1.49B | $1.32B | $1.29B | $1.41B | $1.17B | $1.04B | $930M | $800M | $724M | $631M | $606M | |
| Inventory | $1.02B | $972M | $1.03B | $1.04B | $830M | $720M | $679M | $628M | $575M | $533M | $541M | |
| Other Current Assets | $293M | $334M | $274M | $282M | $222M | $216M | $198M | $190M | $192M | $182M | $294M | |
| Current Assets | $4.59B | $3.96B | $4.19B | $3.78B | $3.80B | $3.42B | $3.19B | $3.87B | $4.17B | $3.63B | $3.69B | |
| PP&E (Net) | $2.02B | $1.78B | $1.27B | $1.10B | $945M | $845M | $850M | $822M | $757M | $639M | $604M | |
| PP&E (Gross) | $3.45B | $3.08B | $2.49B | $2.25B | $2.07B | $1.87B | $1.77B | · | $1.60B | $1.41B | $1.33B | |
| Accum. Depreciation | $1.42B | $1.30B | $1.22B | $1.15B | $1.12B | $1.03B | $925M | · | $843M | $767M | $730M | |
| Goodwill | $4.47B | $4.48B | $3.96B | $3.95B | $3.98B | $3.60B | $3.59B | $2.97B | $2.61B | $2.52B | $2.37B | |
| Intangibles | $445M | $547M | $475M | $821M | $981M | $831M | $1.11B | $491M | $361M | $416M | $445M | |
| Other Non-current Assets | $1.06B | $910M | $708M | $686M | $820M | $776M | $611M | $332M | $394M | $452M | $292M | |
| Total Assets | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.56B | $8.43B | $7.79B | $7.48B | |
| Accounts Payable | $570M | $540M | $418M | $580M | $446M | $354M | $354M | $340M | $305M | $257M | $279M | |
| Short-term Debt | $304M | $45M | $0 | $36M | $0 | $75M | $616M | · | $210M | $0 | $0 | |
| Current Liabilities | $2.35B | $1.90B | $1.60B | $1.86B | $1.71B | $1.47B | $2.08B | $1.16B | $1.26B | $945M | $976M | |
| Capital Leases | $145M | $142M | $118M | $101M | $130M | $127M | $5M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $31M | · | $77M | $65M | $96M | |
| Other Non-current Liabilities | $463M | $578M | $477M | $536M | $659M | $614M | $473M | $763M | $293M | $339M | $414M | |
| Total Liabilities | $5.99B | $5.95B | $4.92B | $5.23B | $5.32B | $4.75B | $4.70B | $3.96B | $3.59B | $3.55B | $3.31B | |
| Long-term Debt | $3.05B | $3.35B | $2.73B | $2.73B | $2.73B | $2.28B | $1.79B | · | $1.79B | $1.89B | $1.60B | |
| Total Debt | $304M | $45M | $0 | $36M | $2.73B | $2.36B | $2.41B | · | $2.01B | $1.91B | $1.66B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $6M | $6M | |
| Paid-in Capital | $5.58B | $5.45B | $5.39B | $5.33B | $5.32B | $5.31B | $5.28B | $5.31B | $5.30B | $9.16B | $9.04B | |
| Retained Earnings | $1.39B | $750M | $782M | $324M | $348M | $81M | $-18M | $-303M | $-126M | $6.09B | $5.58B | |
| Treasury Stock | · | · | · | · | · | · | · | · | $0 | $10.51B | $10.07B | |
| AOCI | $-226M | $-305M | $-327M | $-347M | $-282M | $-522M | $-514M | $-415M | $-346M | $-503M | $-391M | |
| Stockholders' Equity | $6.74B | $5.90B | $5.84B | $5.30B | $5.39B | $4.87B | $4.75B | $4.59B | $4.83B | $4.24B | $4.17B | |
| Liabilities + Equity | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.56B | $8.43B | $7.79B | $7.48B | |
| Shares Outstanding | 283,054,377 | 285,193,011 | 292,123,241 | 295,259,092 | 302,000,000 | 306,000,000 | 309,000,000 | · | 322,000,000 | 614,000,000 | 611,000,000 |
التدفق النقدي 19
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $288M | $257M | $271M | $317M | $321M | $308M | $238M | · | $212M | $246M | $253M | |
| Stock-based Comp | $128M | $129M | $111M | $125M | $110M | $83M | $72M | · | $60M | $58M | $54M | |
| Deferred Tax | $-130M | $-64M | $-56M | $8M | $14M | $29M | $-255M | · | $102M | $3M | $70M | |
| Amort. of Intangibles | $105M | $105M | $140M | $192M | $195M | $186M | $128M | · | $120M | $154M | $158M | |
| Restructuring | $82M | $76M | $46M | · | · | · | · | · | · | · | $6M | |
| Other Non-cash | $-30M | $140M | $206M | $-392M | $-170M | $-218M | $-105M | · | $-169M | $24M | $-287M | |
| Operating Cash Flow | $1.56B | $1.75B | $1.77B | $1.31B | $1.49B | $921M | $1.02B | · | $889M | $793M | $512M | |
| CapEx | $407M | $378M | $298M | $291M | $188M | $119M | $155M | · | $176M | $139M | $98M | |
| Investing Cash Flow | $-394M | $-1.26B | $-310M | $-338M | $-749M | $-147M | $-1.59B | · | $-304M | $-238M | $-400M | |
| Debt Issued | $4M | $1.20B | $0 | $600M | $848M | · | · | · | · | · | · | |
| Net Debt Issued | $1M | $597M | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $425M | $1.15B | $575M | $1.14B | $788M | $469M | $723M | · | $194M | $434M | $267M | |
| Net Stock Activity | $-425M | $-1.15B | $-575M | $-1.14B | $-788M | $-469M | $-723M | · | $-194M | $-434M | $-267M | |
| Dividends Paid | $282M | $274M | $265M | $250M | $236M | $222M | $206M | · | $170M | $150M | $133M | |
| Financing Cash Flow | $-715M | $-752M | $-930M | $-1.37B | $-696M | $-717M | $-299M | · | $-202M | $-268M | $-1.09B | |
| Net Change in Cash | $459M | $-261M | $537M | $-434M | $43M | $59M | $-866M | · | $391M | $286M | $-1.02B | |
| Taxes Paid | $318M | $314M | $199M | $279M | $211M | $361M | $159M | · | · | · | · | |
| Free Cash Flow | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B | $802M | $866M | · | $713M | $654M | $393M | |
| Levered FCF | $1.05B | $1.29B | $1.39B | $951M | $1.22B | $735M | $780M | · | $644M | $589M | $331M |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% | 15.8% | 18.2% | · | 18.8% | 14.6% | 12.9% | |
| Net Margin | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% | 20.7% | · | 15.3% | 11.0% | 9.9% | |
| Pretax Margin | 20.6% | 23.4% | 19.6% | 22.0% | 21.5% | 15.8% | 17.8% | · | 21.8% | 20.4% | 19.0% | |
| EBITDA Margin | 25.4% | 26.8% | 23.7% | 28.3% | 26.4% | 21.6% | 22.8% | · | 23.5% | 20.5% | 19.2% | |
| ROA | 10.6% | 11.4% | 11.7% | 11.8% | 11.9% | 7.5% | 11.9% | · | 8.4% | 6.0% | 4.4% | |
| ROE | 20.6% | 21.9% | 22.2% | 23.4% | 23.6% | 14.9% | 22.9% | · | 15.1% | 11.0% | 8.5% | |
| ROIC | 19.1% | 21.2% | 21.4% | 25.3% | 14.8% | 10.0% | 15.3% | · | 10.8% | 9.0% | 8.5% |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.1 | 2.6 | 2.0 | 2.2 | 2.3 | 1.5 | · | 3.3 | 3.8 | 3.8 | |
| Quick Ratio | 1.4 | 1.4 | 1.8 | 1.3 | 1.6 | 1.7 | 1.1 | · | 2.7 | 3.1 | 2.7 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | |
| LT Debt / Equity | · | · | · | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | |
| Interest Coverage | 13.2 | 15.5 | 14.2 | 19.3 | 16.6 | 10.8 | 12.7 | · | 10.6 | 8.5 | 7.9 |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.4 | |
| Inventory Turnover | 3.3 | 3.0 | 3.3 | 3.3 | 3.8 | 3.6 | 3.6 | · | 3.7 | 3.7 | 3.6 | |
| Receivables Turnover | 4.9 | 5.0 | 5.1 | 5.3 | 5.7 | 5.4 | 6.0 | · | 6.6 | 6.8 | 6.6 |
معدلات النمو 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.7% | -4.7% | -0.22% | 8.4% | 18.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.48% | 1.0% | 8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 3.2% | 5.7% | 0.24% | 6.1% | 71.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.0% | 4.0% | 22.1% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 14.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1.1% | 4.0% | -1.1% | 3.6% | 68.3% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.3% | 2.1% | 19.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | · | $4.47B | $4.20B | $4.04B | |
| Net Income TTM | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719M | $1.07B | · | $684M | $462M | $401M | |
| Market Cap | $41.43B | $37.16B | $30.20B | $40.81B | $47.56B | $31.24B | · | · | · | · | · | |
| Enterprise Value | $39.94B | $35.88B | $28.61B | $39.80B | $48.81B | $32.16B | · | · | · | · | · | |
| P/E | 32.0 | 29.4 | 24.7 | 33.1 | 40.0 | 44.4 | 22.5 | · | 32.4 | 31.1 | 31.5 | |
| P/S | 6.0 | 5.7 | 4.4 | 6.0 | 7.5 | 5.9 | · | · | · | · | · | |
| P/B | 6.1 | 6.3 | 5.2 | 7.7 | 8.8 | 6.4 | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 42.5 | 21.4 | 76.7 | 109.8 | 71.0 | · | · | · | · | · | |
| P / Cash Flow | 26.6 | 21.2 | 17.0 | 31.1 | 32.0 | 33.9 | · | · | · | · | · | |
| P / FCF | 36.0 | 27.1 | 20.5 | 40.0 | 36.7 | 39.0 | · | · | · | · | · | |
| EV / EBITDA | 22.6 | 20.6 | 17.6 | 20.6 | 29.3 | 27.9 | · | · | · | · | · | |
| EV / FCF | 34.7 | 26.1 | 19.4 | 39.0 | 37.6 | 40.1 | · | · | · | · | · | |
| EV / Revenue | 5.7 | 5.5 | 4.2 | 5.8 | 7.7 | 6.0 | · | · | · | · | · | |
| Dividend Yield | 0.68% | 0.74% | 0.88% | 0.61% | 0.50% | 0.71% | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.4% | 4.0% | 3.0% | 2.5% | 2.2% | 4.5% | · | 3.1% | 3.2% | 3.2% | |
| Payout Ratio | 21.6% | 21.3% | 21.4% | 19.9% | 19.5% | 30.9% | 19.2% | · | 24.9% | 32.5% | 33.2% | |
| Annual Payout | $282M | $274M | $265M | $250M | $236M | $222M | $206M | · | $170M | $150M | $133M |
قائمة الدخل 17
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83B | $1.80B | $1.86B | $1.74B | $1.67B | $1.68B | $1.70B | $1.58B | $1.57B | $1.66B | $1.69B | $1.67B | $1.72B | $1.76B | $1.85B | $1.72B | |
| Cost of Revenue | $845M | $852M | $871M | $850M | $802M | $782M | $785M | $723M | $717M | $750M | $773M | $1.01B | $793M | $788M | $837M | $779M | |
| R&D Expense | $126M | $117M | $119M | $111M | $112M | $113M | $111M | $127M | $113M | $128M | $114M | $118M | $126M | $123M | $119M | $116M | |
| SG&A Expense | $465M | $476M | $428M | $417M | $454M | $410M | $397M | $395M | $380M | $396M | $393M | $407M | $415M | $419M | $422M | $412M | |
| Operating Expenses | $1.44B | $1.45B | $1.42B | $1.38B | $1.37B | $1.30B | $1.29B | $1.25B | $1.21B | $1.27B | $1.28B | $1.54B | $1.33B | $1.33B | $1.38B | $1.31B | |
| Operating Income | $399M | $353M | $443M | $360M | $300M | $376M | $408M | $333M | $363M | $384M | $408M | $133M | $383M | $426M | $471M | $411M | |
| Interest Expense | $25M | $25M | $27M | $28M | $29M | $28M | $32M | $22M | $20M | $22M | $22M | $24M | $24M | $25M | $23M | $19M | |
| Interest Income | $13M | $15M | $17M | $16M | $14M | $15M | $24M | $19M | $19M | $18M | $17M | $13M | $12M | $9M | $5M | $2M | |
| Other Non-op | $21M | $21M | $9M | $18M | $-25M | $4M | $1M | $13M | $12M | $23M | $17M | $10M | $6M | $0 | $2M | $3M | |
| Pretax Income | $408M | $364M | $442M | $366M | $260M | $367M | $401M | $343M | $374M | $403M | $420M | $132M | $377M | $410M | $455M | $397M | |
| Income Tax | $69M | $59M | $8M | $30M | $45M | $49M | $50M | $61M | $66M | $55M | $-55M | $21M | $75M | $58M | $87M | $68M | |
| Net Income | $339M | $305M | $434M | $336M | $215M | $318M | $351M | $282M | $308M | $348M | $475M | $111M | $302M | $352M | $368M | $329M | |
| EPS (Basic) | $1.20 | $1.08 | $1.54 | $1.18 | $0.75 | $1.12 | $1.23 | $0.97 | $1.05 | $1.19 | $1.63 | $0.38 | $1.02 | $1.19 | $1.23 | $1.10 | |
| EPS (Diluted) | $1.20 | $1.07 | $1.53 | $1.18 | $0.75 | $1.11 | $1.23 | $0.97 | $1.05 | $1.18 | $1.60 | $0.38 | $1.02 | $1.19 | $1.24 | $1.10 | |
| Shares (Basic) | 282,000,000 | 283,000,000 | -570,000,000 | 284,000,000 | 285,000,000 | 285,000,000 | -586,000,000 | 290,000,000 | 293,000,000 | 293,000,000 | -592,000,000 | 294,000,000 | 296,000,000 | 296,000,000 | -599,000,000 | 298,000,000 | |
| Shares (Diluted) | 283,000,000 | 284,000,000 | -572,000,000 | 285,000,000 | 285,000,000 | 287,000,000 | -587,000,000 | 291,000,000 | 293,000,000 | 294,000,000 | -593,000,000 | 295,000,000 | 297,000,000 | 297,000,000 | -603,000,000 | 299,000,000 | |
| EBITDA | $399M | $420M | · | $360M | $300M | $448M | · | $333M | $363M | $446M | · | $133M | $383M | $493M | · | $411M |
الميزانية العمومية 27
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B | $1.67B | $1.75B | $1.59B | $1.33B | $1.18B | $1.25B | $1.05B | $1.07B | |
| Receivables | $1.50B | $1.52B | $1.49B | $1.38B | $1.37B | $1.33B | $1.32B | $1.23B | $1.25B | $1.29B | · | $1.34B | $1.40B | $1.46B | · | $1.34B | |
| Inventory | $1.09B | $1.06B | $1.02B | $1.01B | $991M | $997M | $972M | $978M | $1.00B | $1.03B | · | $1.07B | $1.10B | $1.11B | · | $1.01B | |
| Other Current Assets | $369M | $277M | $293M | $322M | $365M | $315M | $334M | $272M | $283M | $262M | · | $290M | $270M | $258M | · | $258M | |
| Current Assets | $4.76B | $4.62B | $4.59B | $4.25B | $4.21B | $4.11B | $3.96B | $4.26B | $4.20B | $4.34B | · | $4.03B | $3.95B | $4.08B | · | $3.69B | |
| PP&E (Net) | $2.10B | $2.08B | $2.02B | $1.97B | $1.91B | $1.82B | $1.78B | $1.45B | $1.37B | $1.31B | · | $1.21B | $1.18B | $1.15B | · | $1.05B | |
| PP&E (Gross) | · | · | $3.45B | · | · | · | $3.08B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.42B | · | · | · | $1.30B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $4.48B | $4.48B | $4.47B | $4.47B | $4.47B | $4.43B | $4.48B | $3.96B | $3.96B | $3.97B | $3.96B | $3.98B | $3.98B | $3.98B | $3.95B | $3.95B | |
| Intangibles | $407M | $426M | $445M | $469M | $495M | $514M | $547M | $392M | $417M | $443M | · | $502M | $798M | $810M | · | $849M | |
| Other Non-current Assets | $1.18B | $1.07B | $1.06B | $930M | $934M | $875M | $910M | $751M | $725M | $716M | · | $758M | $695M | $713M | · | $749M | |
| Total Assets | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | · | $10.68B | $10.79B | $10.92B | · | $10.48B | |
| Accounts Payable | $615M | $602M | $570M | $530M | $517M | $547M | $540M | $497M | $461M | $488M | · | $452M | $479M | $540M | · | $558M | |
| Short-term Debt | $304M | $304M | $304M | $59M | $146M | $16M | $45M | $795M | $420M | · | · | $55M | $0 | $238M | · | $180M | |
| Current Liabilities | $2.27B | $2.23B | $2.35B | $1.89B | $2.01B | $1.87B | $1.90B | $2.39B | $1.96B | $1.62B | · | $1.76B | $1.67B | $1.94B | · | $1.90B | |
| Capital Leases | · | · | $145M | · | · | · | $142M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $496M | $491M | $463M | $495M | $535M | $551M | $578M | $471M | $449M | $486M | · | $531M | $515M | $542M | · | $583M | |
| Total Liabilities | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B | $4.64B | $4.76B | · | $5.12B | $5.01B | $5.31B | · | $5.39B | |
| Long-term Debt | $3.05B | $3.05B | $3.05B | $3.35B | $3.35B | $3.35B | $3.35B | $2.14B | $2.14B | $2.56B | · | $2.73B | $2.73B | $2.73B | · | $2.73B | |
| Total Debt | $304M | $304M | · | $59M | $146M | $16M | · | $795M | $420M | · | · | $55M | $0 | $238M | · | $180M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Paid-in Capital | $5.63B | $5.61B | $5.58B | $5.55B | $5.50B | $5.49B | $5.45B | $5.46B | $5.46B | $5.44B | · | $5.38B | $5.36B | $5.34B | · | $5.31B | |
| Retained Earnings | $1.69B | $1.48B | $1.39B | $1.10B | $912M | $916M | $750M | $773M | $1.09B | $1.06B | · | $444M | $700M | $541M | · | $139M | |
| AOCI | $-202M | $-184M | $-226M | $-283M | $-280M | $-381M | $-305M | $-331M | $-337M | $-316M | · | $-271M | $-282M | $-280M | $-347M | $-362M | |
| Stockholders' Equity | $7.12B | $6.91B | $6.74B | $6.37B | $6.14B | $6.03B | $5.90B | $5.90B | $6.21B | $6.19B | · | $5.56B | $5.78B | $5.61B | · | $5.09B | |
| Liabilities + Equity | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | · | $10.68B | $10.79B | $10.92B | · | $10.48B | |
| Shares Outstanding | 282,218,158 | 282,695,763 | 283,054,377 | 283,593,838 | 283,936,028 | 285,232,190 | 285,193,011 | 287,529,636 | 291,587,707 | 293,041,817 | · | 293,000,000 | 295,000,000 | 296,000,000 | · | 296,000,000 |
التدفق النقدي 19
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $71M | $72M | $73M | $72M | $69M | $63M | $63M | $62M | $62M | $71M | $71M | $67M | $73M | $80M | |
| Stock-based Comp | $32M | $41M | $26M | $32M | $30M | $40M | $26M | $28M | $31M | $44M | $14M | $29M | $24M | $44M | $26M | $28M | |
| Deferred Tax | $32M | $25M | $-95M | $-7M | $-18M | $-10M | $-56M | $-1M | $-7M | $0 | $13M | $-68M | $-5M | $4M | $-17M | $6M | |
| Amort. of Intangibles | $19M | $19M | $24M | $26M | $27M | $28M | $27M | $25M | $27M | $26M | $27M | $39M | $38M | $36M | $42M | $48M | |
| Restructuring | $8M | $20M | $8M | $17M | $56M | $1M | $5M | $67M | $1M | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-170M | · | · | · | $11M | · | · | · | $31M | · | · | · | $-171M | · | · | |
| Operating Cash Flow | $277M | $268M | $545M | $362M | $221M | $431M | $481M | $452M | $333M | $485M | $516M | $562M | $398M | $296M | $448M | $326M | |
| CapEx | $76M | $93M | $93M | $103M | $114M | $97M | $93M | $92M | $103M | $90M | $84M | $81M | $57M | $76M | $70M | $82M | |
| Investing Cash Flow | $-77M | $-93M | $-90M | $-96M | $-114M | $-94M | $-954M | $-100M | $-109M | $-95M | $-40M | $-89M | $-77M | $-104M | $-110M | $-73M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $4M | $1.20B | $0 | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Debt Issued | · | $-2M | · | · | · | $3M | · | · | · | $-180M | · | · | · | · | · | · | |
| Stock Repurchased | $65M | $152M | $85M | $85M | $165M | $90M | $335M | $585M | $230M | $0 | $80M | $335M | $85M | $75M | $135M | $323M | |
| Net Stock Activity | · | $-152M | · | · | · | $-90M | · | · | · | $0 | · | · | · | $-75M | · | · | |
| Dividends Paid | $72M | $72M | $70M | $71M | $70M | $71M | $68M | $68M | $69M | $69M | $66M | $66M | $66M | $67M | $62M | $62M | |
| Financing Cash Flow | $-144M | $-222M | $-200M | $-219M | $-116M | $-180M | $25M | $-246M | $-291M | $-240M | $-201M | $-322M | $-390M | $-17M | $-341M | $-362M | |
| Net Change in Cash | $49M | $-31M | $254M | $48M | $19M | $138M | $-450M | $108M | $-76M | $157M | $261M | $154M | $-75M | $197M | $-17M | $-115M | |
| Taxes Paid | $215M | $105M | $14M | $56M | $229M | $19M | $30M | $60M | $200M | $24M | $56M | $15M | $111M | $17M | $62M | $83M | |
| Free Cash Flow | · | $175M | · | · | · | $334M | · | · | · | $395M | · | · | · | $220M | · | · | |
| Levered FCF | · | $154M | · | · | · | $310M | · | · | · | $376M | · | · | · | $199M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 21.7% | 19.6% | · | 20.7% | 18.0% | 22.4% | · | 21.1% | 23.1% | 23.2% | · | 8.0% | 22.3% | 24.3% | · | 23.9% | |
| Net Margin | 18.5% | 17.0% | · | 19.3% | 12.9% | 18.9% | · | 17.9% | 19.6% | 21.0% | · | 6.6% | 17.6% | 20.1% | · | 19.1% | |
| Pretax Margin | 22.2% | 20.2% | · | 21.1% | 15.6% | 21.8% | · | 21.7% | 23.8% | 24.3% | · | 7.9% | 22.0% | 23.4% | · | 23.1% | |
| EBITDA Margin | 21.7% | 23.4% | · | 20.7% | 18.0% | 26.7% | · | 21.1% | 23.1% | 26.9% | · | 8.0% | 22.3% | 28.1% | · | 23.9% | |
| ROA | 2.7% | 2.5% | · | 2.9% | 1.9% | 2.8% | · | 2.6% | 2.9% | 3.2% | · | 1.1% | 2.8% | 3.3% | · | 3.1% | |
| ROE | 5.1% | 4.7% | · | 5.5% | 3.5% | 5.2% | · | 4.9% | 5.1% | 5.9% | · | 2.1% | 5.5% | 6.5% | · | 6.6% | |
| ROIC | 4.5% | 4.1% | · | 5.1% | 4.0% | 5.4% | · | 4.1% | 4.5% | 5.4% | · | 2.0% | 5.3% | 6.3% | · | 6.5% |
السيولة والملاءة 4
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.1 | · | 2.2 | 2.1 | 2.2 | · | 1.8 | 2.1 | 2.7 | · | 2.3 | 2.4 | 2.1 | · | 1.9 | |
| Quick Ratio | 1.5 | 1.5 | · | 1.5 | 1.4 | 1.5 | · | 1.3 | 1.5 | 1.9 | · | 1.5 | 1.5 | 1.4 | · | 1.3 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | 16.0 | 14.1 | · | 12.9 | 10.3 | 13.4 | · | 15.1 | 18.1 | 17.5 | · | 5.5 | 16.0 | 17.0 | · | 21.6 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
التقييم (آخر 12 شهرًا) 17
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7.04B | $6.88B | · | $6.67B | $6.50B | $6.49B | · | $6.48B | $6.62B | $6.80B | · | $6.86B | $6.80B | $6.75B | · | $6.58B | |
| Net Income TTM | $1.20B | $1.17B | · | $1.15B | $1.12B | $1.26B | · | $1.05B | $1.07B | $1.11B | · | $1.09B | $1.26B | $1.24B | · | $1.15B | |
| Market Cap | $32.61B | $37.84B | · | $32.56B | $30.55B | $43.22B | · | $40.66B | $39.96B | $38.12B | · | $35.68B | $39.95B | $45.02B | · | $39.69B | |
| Enterprise Value | $31.11B | $36.38B | · | $31.08B | $29.21B | $41.77B | · | $39.67B | $38.71B | · | · | $34.40B | $38.78B | $44.00B | · | $38.80B | |
| P/E | 27.5 | 32.6 | · | 28.6 | 27.7 | 35.2 | · | 39.5 | 37.8 | 34.5 | · | 33.0 | 32.1 | 36.8 | · | 35.3 | |
| P/S | 4.6 | 5.5 | · | 4.9 | 4.7 | 6.7 | · | 6.3 | 6.0 | 5.6 | · | 5.2 | 5.9 | 6.7 | · | 6.0 | |
| P/B | 4.6 | 5.5 | · | 5.1 | 5.0 | 7.2 | · | 6.9 | 6.4 | 6.2 | · | 6.4 | 6.9 | 8.0 | · | 7.8 | |
| P / Tangible Book | 14.6 | 18.9 | · | 22.8 | 26.2 | 39.9 | · | 26.3 | 21.8 | 21.4 | · | 33.3 | 39.8 | 55.2 | · | 135.0 | |
| P / Cash Flow | · | 141.2 | · | · | · | 100.3 | · | · | · | 78.6 | · | · | · | 152.1 | · | · | |
| P / FCF | · | 216.2 | · | · | · | 129.4 | · | · | · | 96.5 | · | · | · | 204.6 | · | · | |
| EV / EBITDA | 78.0 | 86.6 | · | 86.3 | 97.4 | 93.2 | · | 119.1 | 106.6 | · | · | 258.7 | 101.2 | 89.3 | · | 94.4 | |
| EV / FCF | · | 207.9 | · | · | · | 125.1 | · | · | · | · | · | · | · | 200.0 | · | · | |
| EV / Revenue | 4.4 | 5.3 | · | 4.7 | 4.5 | 6.4 | · | 6.1 | 5.8 | · | · | 5.0 | 5.7 | 6.5 | · | 5.9 | |
| Dividend Yield | 0.87% | 0.75% | · | 0.86% | 0.91% | 0.64% | · | 0.67% | 0.68% | 0.70% | · | 0.73% | 0.65% | 0.57% | · | 0.62% | |
| Earnings Yield | 3.6% | 3.1% | · | 3.5% | 3.6% | 2.8% | · | 2.5% | 2.6% | 2.9% | · | 3.0% | 3.1% | 2.7% | · | 2.8% | |
| Payout Ratio | 21.2% | 23.6% | · | 21.1% | 32.6% | 22.3% | · | 24.1% | 22.4% | 19.8% | · | 59.5% | 21.9% | 19.0% | · | 18.8% | |
| Annual Payout | $285M | $284M | · | $280M | $278M | $277M | · | $272M | $270M | $268M | · | $261M | $258M | $255M | · | $247M |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| الإيرادات | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| هامش الربح التشغيلي % | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% |
| صافي الدخل | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| EPS المخفف | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
الميزانية العمومية
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| النسبة الحالية | 2.0 | 2.1 | 2.6 | 2.0 | 2.2 |
| النسبة السريعة | 1.4 | 1.4 | 1.8 | 1.3 | 1.6 |
التدفق النقدي
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 1222 مقدمي إقرار · $26.2B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 151 (+31 مقابل الربع السابق) | 76 (-76 مقابل الربع السابق) | 431 (+50 مقابل الربع السابق) | 339 (-36 مقابل الربع السابق) | +53.4M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4259623862 | 31304651 | 16,26% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $2450695036 | 18449861 | 9,35% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1918389438 | 14442441 | 7,32% | الأسهم |
| STATE STREET CORP | $1710658167 | 12854230 | 6,53% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $978381680 | 7365668 | 3,73% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $913419841 | 6876608 | 3,49% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $881928971 | 6669587 | 3,37% | الأسهم |
| Pictet Asset Management Holding SA | $596979330 | 4494311 | 2,28% | الأسهم |
| NORGES BANK | $513991530 | 3869544 | 1,96% | الأسهم |
| FMR LLC | $496375681 | 3736924 | 1,89% | الأسهم |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $367735737 | 2768469 | 1,40% | الأسهم |
| Troy Asset Management Ltd | $355539021 | 2676647 | 1,36% | الأسهم |
| GOLDMAN SACHS GROUP INC | $301597289 | 2270551 | 1,15% | الأسهم |
| FIRST TRUST ADVISORS LP | $276230248 | 2079578 | 1,05% | الأسهم |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $261614131 | 1969541 | 1,00% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $259427413 | 1953078 | 0,99% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $256612683 | 1931888 | 0,98% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $245065240 | 1844954 | 0,94% | الأسهم |
| Impax Asset Management Group plc | $222484548 | 1674957 | 0,85% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $210722973 | 1586411 | 0,80% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $192780430 | 1451332 | 0,74% | الأسهم |
| Qube Research & Technologies Ltd | $188002734 | 1415364 | 0,72% | الأسهم |
| Candriam S.C.A. | $179443631 | 1352228 | 0,68% | الأسهم |
| PRIMECAP MANAGEMENT CO/CA/ | $176318012 | 1327396 | 0,67% | الأسهم |
| Bank of New York Mellon Corp | $175956447 | 1324674 | 0,67% | الأسهم |
| Findlay Park Partners LLP | $174281328 | 1312063 | 0,67% | الأسهم |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $170987393 | 1287265 | 0,65% | الأسهم |
| VAN ECK ASSOCIATES CORP | $163847133 | 1233510 | 0,63% | الأسهم |
| CITADEL ADVISORS LLC | $141805854 | 1067574 | 0,54% | الأسهم |
| JUPITER ASSET MANAGEMENT LTD | $137850416 | 1046214 | 0,53% | الأسهم |
| Robeco Schweiz AG | $133837515 | 1007585 | 0,51% | الأسهم |
| TD Asset Management Inc | $132416102 | 996884 | 0,51% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $125377572 | 943900 | 0,48% | الأسهم |
| BlackRock, Inc. | $116504263 | 877093 | 0,44% | الأسهم |
| Quantinno Capital Management LP | $115638237 | 870573 | 0,44% | الأسهم |
| Alyeska Investment Group, L.P. | $108252598 | 814971 | 0,41% | الأسهم |
| Swiss National Bank | $105892076 | 797200 | 0,40% | الأسهم |
| Scharf Investments, LLC | $100176558 | 754161 | 0,38% | الأسهم |
| Legal & General Group Plc | $98122318 | 738706 | 0,37% | الأسهم |
| Liontrust Investment Partners LLP | $96037390 | 705794 | 0,37% | الأسهم |
| M&G PLC | $95397309 | 717273 | 0,36% | الأسهم |
| Madison Investment Advisors, LLC | $94050693 | 700094 | 0,36% | الأسهم |
| Mitsubishi UFJ Asset Management Co., Ltd. | $92358027 | 695310 | 0,35% | الأسهم |
| Freestone Grove Partners LP | $91081398 | 685699 | 0,35% | الأسهم |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $90900351 | 684336 | 0,35% | الأسهم |
| SUMMITRY LLC | $88508881 | 666332 | 0,34% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $87994562 | 662460 | 0,34% | الأسهم |
| AMERIPRISE FINANCIAL INC | $87419975 | 658029 | 0,33% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $85742481 | 752259 | 0,33% | الأسهم |
| LAZARD ASSET MANAGEMENT LLC | $85180425 | 641274 | 0,33% | الأسهم |
| Madison Asset Management, LLC | $83917028 | 631763 | 0,32% | الأسهم |
| JENNISON ASSOCIATES LLC | $82524356 | 621278 | 0,31% | الأسهم |
| Sumitomo Mitsui Trust Group, Inc. | $81741191 | 615382 | 0,31% | الأسهم |
| Vanguard Global Advisers, LLC | $80906886 | 609101 | 0,31% | الأسهم |
| PARNASSUS INVESTMENTS, LLC | $80640827 | 607098 | 0,31% | الأسهم |
| California Public Employees Retirement System | $79884892 | 601407 | 0,30% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $75494859 | 568162 | 0,29% | الأسهم |
| Fenimore Asset Management Inc | $74567504 | 561375 | 0,28% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $72868280 | 548583 | 0,28% | الأسهم |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $72747936 | 547677 | 0,28% | الأسهم |
| Harvest Portfolios Group Inc. | $70685352 | 532149 | 0,27% | الأسهم |
| JANE STREET GROUP, LLC | $69842014 | 525800 | 0,27% | عقد خيار البيع |
| Select Equity Group, L.P. | $68419936 | 515094 | 0,26% | الأسهم |
| RHUMBLINE ADVISERS | $66522113 | 500807 | 0,25% | الأسهم |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $63471621 | 477841 | 0,24% | الأسهم |
| National Pension Service | $62363818 | 469501 | 0,24% | الأسهم |
| Squarepoint Ops LLC | $61937832 | 466294 | 0,24% | الأسهم |
| BARCLAYS PLC | $61183224 | 460613 | 0,23% | الأسهم |
| EARNEST PARTNERS LLC | $59928911 | 451170 | 0,23% | الأسهم |
| BANK OF NOVA SCOTIA | $58538579 | 440703 | 0,22% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $57724332 | 434573 | 0,22% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $57355994 | 431800 | 0,22% | عقد خيار الشراء |
| DAVENPORT & Co LLC | $57354874 | 431792 | 0,22% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49992426 | 438607 | 0,19% | الأسهم |
| D. E. Shaw & Co., Inc. | $47442758 | 357169 | 0,18% | الأسهم |
| Susquehanna Portfolio Strategies, LLC | $46586802 | 350725 | 0,18% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $43801225 | 329754 | 0,17% | الأسهم |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $43116220 | 324597 | 0,16% | الأسهم |
| CITADEL ADVISORS LLC | $42784543 | 322100 | 0,16% | عقد خيار الشراء |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42660480 | 321166 | 0,16% | الأسهم |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $41663724 | 313662 | 0,16% | الأسهم |
| Swedbank AB | $39972666 | 300931 | 0,15% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39596623 | 298100 | 0,15% | عقد خيار البيع |
| Robeco Institutional Asset Management B.V. | $39088283 | 294273 | 0,15% | الأسهم |
| Northwest & Ethical Investments L.P. | $35746445 | 269114 | 0,14% | الأسهم |
| Gotham Asset Management, LLC | $34062261 | 256435 | 0,13% | الأسهم |
| AVIVA PLC | $32455417 | 244338 | 0,12% | الأسهم |
| Corient Private Wealth LP | $32351707 | 243555 | 0,12% | الأسهم |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $31475662 | 236962 | 0,12% | الأسهم |
| Aberdeen Group plc | $31361030 | 236099 | 0,12% | الأسهم |
| Polar Capital Holdings Plc | $28652361 | 215707 | 0,11% | الأسهم |
| ASSETMARK, INC | $28532974 | 214808 | 0,11% | الأسهم |
| Eurizon Capital SGR S.p.A. | $27472791 | 206818 | 0,10% | الأسهم |
| DANSKE BANK A/S | $26955989 | 202936 | 0,10% | الأسهم |
| DKRT Investments Corp. | $26566000 | 200000 | 0,10% | الأسهم |
| HSBC HOLDINGS PLC | $26124912 | 198006 | 0,10% | الأسهم |
| ROYAL BANK OF CANADA | $25054000 | 188614 | 0,10% | الأسهم |
| Epoch Investment Partners, Inc. | $24780233 | 186556 | 0,09% | الأسهم |
| STRS OHIO | $24668258 | 185713 | 0,09% | الأسهم |
| NATIONAL BANK OF CANADA /FI/ | $24547914 | 184807 | 0,09% | الأسهم |
المطلعون على الشركة 65 من المطلعين · مسؤولون 39 · مديرون 23
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| MCDONNELL PADRAIG | President and CEO | 3 يونيو، 2026 F | 65842 | 0 | 3 | $-2253752 |
| Michael R. Mcmullen | CEO and President | 8 مارس، 2024 S | 253909 | 0 | 0 | $0 |
| William P Sullivan | CEO | 1 ديسمبر، 2014 S | 458167 | 0 | 0 | $0 |
| Adam Stewart Elinoff | Senior Vice President and CFO | 18 نوفمبر، 2025 A | 11726 | 0 | 0 | $0 |
| Robert W. Mcmahon | Sr. VP and CFO | 22 مايو، 2025 F | 168754 | 0 | 0 | $0 |
| Didier Hirsch | Sr. VP and CFO | 7 ديسمبر، 2017 F | 184432 | 0 | 0 | $0 |
| Adrian T Dillon | EVP, Finance & Admin., CFO | 30 مارس، 2010 M | 129925 | 0 | 0 | $0 |
| Jonah Prevost Kirkwood | Senior Vice President | 26 يونيو، 2026 F | 14108 | 0 | 0 | $0 |
| Michael Steven Buckner | Senior Vice President | 19 مايو، 2026 A | 8887 | 0 | 0 | $0 |
| Simon May | Senior Vice President | 8 مايو، 2026 F | 14015 | 0 | 0 | $0 |
| Meghan Henson | Senior Vice President | 31 مارس، 2026 F | 6890 | 0 | 0 | $0 |
| Angelica Riemann | Senior Vice President | 27 فبراير، 2026 F | 26535 | 0 | 0 | $0 |
| Jianmiao Mike Zhang | Senior Vice President | 26 نوفمبر، 2025 F | 11639 | 0 | 0 | $0 |
| Rodney Gonsalves | V.P., Corporate Controller | 26 نوفمبر، 2025 G | 0 | 0 | 1 | $-464970 |
| Bret Dimarco | Senior Vice President | 26 نوفمبر، 2025 F | 12203 | 0 | 0 | $0 |
| Henrik Ancher-Jensen | Sr Vice President | 30 مايو، 2025 F | 86426 | 0 | 0 | $0 |
| Philip Binns | Senior Vice President | 19 نوفمبر، 2024 A | 10650 | 0 | 0 | $0 |
| Dominique Grau | Senior Vice President | 26 سبتمبر، 2024 S | 46762 | 0 | 0 | $0 |
| Michael Tang | SVP, General Counsel, and Sec. | 22 نوفمبر، 2023 A | 54872 | 0 | 0 | $0 |
| Samraat S. Raha | Sr. Vice President | 14 نوفمبر، 2023 F | 87196 | 0 | 0 | $0 |
| Jacob Thaysen | Sr. Vice President | 1 ديسمبر، 2022 S | 84464 | 0 | 0 | $0 |
| Mark Doak | Sr. Vice President | 3 مارس، 2020 S | 135678 | 0 | 0 | $0 |
| Patrick Kaltenbach | Sr Vice President | 29 مارس، 2018 M | 68547 | 0 | 0 | $0 |
| Marie Oh Huber | Sr VP, General Counsel & Sec. | 3 مارس، 2015 M | 44772 | 0 | 0 | $0 |
| Solange Glaize | VP, Chief Accounting Officer | 20 فبراير، 2015 M | 5370 | 0 | 0 | $0 |
| Fred Strohmeier | Senior Vice President | 19 نوفمبر، 2014 A | 27496 | 0 | 0 | $0 |
| Guy Sene | Senior Vice President | 2 سبتمبر، 2014 M | 32713 | 0 | 0 | $0 |
| Jean Halloran | Senior Vice President | 17 يونيو، 2014 M | 74962 | 0 | 0 | $0 |
| Ronald S. Nersesian | Executive Vice President | 21 نوفمبر، 2013 M | 102821 | 0 | 0 | $0 |
| Lars Holmkvist | Senior Vice President | 20 نوفمبر، 2013 A | — | 0 | 0 | $0 |
| Nicolas H Roelofs PHD | Senior Vice President | 28 مارس، 2013 M | 84136 | 0 | 0 | $0 |
| Saleem N. Odeh | Vice President | 18 نوفمبر، 2009 A | 22540 | 0 | 0 | $0 |
| Lonnie G. Justice | Vice President | 18 نوفمبر، 2009 A | 32742 | 0 | 0 | $0 |
| Soon Chai Gooi | Vice President | 18 نوفمبر، 2009 A | 27285 | 0 | 0 | $0 |
| David S Churchill | Vice President | 18 نوفمبر، 2009 F | 25602 | 0 | 0 | $0 |
| Chris Van Ingen | Senior Vice President | 31 أكتوبر، 2007 J | 62083 | 0 | 0 | $0 |
| Thomas White | Senior Vice President | 28 إبريل، 2006 A | 16331 | 0 | 0 | $0 |
| Jack P Trautman | Senior Vice President | 29 إبريل، 2005 A | 12343 | 0 | 0 | $0 |
| Dick M Chang | Senior Vice President | 29 إبريل، 2005 A | 7174 | 0 | 0 | $0 |
| Mikael Dolsten | مدير | 29 مايو، 2026 S | 5548 | 0 | 2 | $-606178 |
| Pascal Soriot | مدير | 19 مارس، 2026 F | 2683 | 0 | 0 | $0 |
| Mala Anand | مدير | 19 مارس، 2026 A | 16705 | 0 | 0 | $0 |
| Daniel K Podolsky | مدير | 19 مارس، 2026 A | 38180 | 0 | 0 | $0 |
| Sue H. Rataj | مدير | 19 مارس، 2026 A | 23617 | 0 | 0 | $0 |
| Judy L Brown | مدير | 19 مارس، 2026 A | 3835 | 0 | 0 | $0 |
| Dow R Wilson | مدير | 19 مارس، 2026 A | 20369 | 0 | 0 | $0 |
| Boon Hwee Koh | مدير | 19 مارس، 2026 F | 63184 | 0 | 0 | $0 |
| Otis W Brawley | مدير | 19 مارس، 2026 A | 13874 | 0 | 0 | $0 |
| George A Scangos | مدير | 19 مارس، 2026 A | 23857 | 0 | 0 | $0 |
| Heidi Kunz | مدير | 14 مارس، 2025 A | 58851 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 1 حيازة
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. | 16 إبريل، 2007 | — | إيداع أولي | اندماج واستحواذ / بيع | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 180 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| PHO · Invesco Exchange-Traded Fund Trust | 3,90% | 559512 SH | 8 أغسطس، 2026 | يومي |
| KAT · Advisors Series Trust | 3,04% | 179660 NS | 31 مارس، 2026 | N-PORT |
| GKAT · Advisors Series Trust | 3,00% | 39208 NS | 31 مارس، 2026 | N-PORT |
| PIO · Invesco Exchange-Traded Fund Trust … | 2,89% | 56131 SH | 8 أغسطس، 2026 | يومي |
| GDOC · Goldman Sachs ETF Trust | 2,77% | 4105 NS | 31 مايو، 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1,89% | 24916 SH | 8 أغسطس، 2026 | يومي |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,68% | 90084 SH | 8 أغسطس، 2026 | يومي |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,62% | 7491 NS | 30 إبريل، 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 1,27% | 3201 NS | 31 مايو، 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,18% | 461 NS | 30 إبريل، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,88% | 66406 NS | 30 إبريل، 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,82% | 2162223 SH | 8 أغسطس، 2026 | يومي |
| JOET · Virtus ETF Trust II | 0,79% | 16177 NS | 30 إبريل، 2026 | N-PORT |
| IYH · iShares Trust | 0,65% | 169194 SH | 8 أغسطس، 2026 | يومي |
| KRMA · Global X Funds | 0,58% | 5164 NS | 31 مايو، 2026 | N-PORT |
| LCLG · Advisors Series Trust | 0,57% | 5020 NS | 30 إبريل، 2026 | N-PORT |
| RXL · ProShares Trust | 0,55% | 2949 NS | 31 مايو، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,55% | 849670 SH | 8 أغسطس، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,53% | 130688 NS | 30 إبريل، 2026 | N-PORT |
| GSY · Invesco Actively Managed Exchange-T… | 0,52% | 20000000 | 8 أغسطس، 2026 | يومي |
| IXJ · iShares Trust | 0,50% | 148250 SH | 8 أغسطس، 2026 | يومي |
| NULC · Nushares ETF Trust | 0,50% | 2455 NS | 30 إبريل، 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,47% | 5640 NS | 30 إبريل، 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,44% | 41201 NS | 30 إبريل، 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,40% | 11883 NS | 31 مايو، 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,39% | 1301 NS | 30 إبريل، 2026 | N-PORT |
| IWS · iShares Trust | 0,38% | 426163 SH | 8 أغسطس، 2026 | يومي |
| GNOM · Global X Funds | 0,38% | 1553 NS | 31 مايو، 2026 | N-PORT |
| ACGR · AMERICAN CENTURY ETF TRUST | 0,37% | 310 NS | 31 مايو، 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,36% | 6116302 SH | 8 أغسطس، 2026 | يومي |
| SFGV · EA Series Trust | 0,34% | 28465 NS | 29 مايو، 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0,34% | 7696 NS | 31 مايو، 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 0,31% | 1211 NS | 30 إبريل، 2026 | N-PORT |
| IWR · iShares Trust | 0,29% | 1149977 SH | 8 أغسطس، 2026 | يومي |
| IMCV · iShares Trust | 0,28% | 23013 SH | 8 أغسطس، 2026 | يومي |
| IMCB · iShares Trust | 0,27% | 32787 SH | 8 أغسطس، 2026 | يومي |
| NUMV · Nushares ETF Trust | 0,27% | 10213 NS | 30 إبريل، 2026 | N-PORT |
| SUSA · iShares Trust | 0,27% | 78831 SH | 8 أغسطس، 2026 | يومي |
| IMCG · iShares Trust | 0,27% | 76769 SH | 8 أغسطس، 2026 | يومي |
| DFLV · Dimensional ETF Trust | 0,25% | 129056 NS | 30 إبريل، 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 7180 SH | 8 أغسطس، 2026 | يومي |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 8663 NS | 30 إبريل، 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,23% | 30784 SH | 8 أغسطس، 2026 | يومي |
| XT · iShares Trust | 0,23% | 62639 SH | 8 أغسطس، 2026 | يومي |
| GSEW · Goldman Sachs ETF Trust | 0,22% | 29372 NS | 31 مايو، 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,22% | 3514 NS | 31 مايو، 2026 | N-PORT |
| XOEF · iShares Trust | 0,22% | 355 SH | 8 أغسطس، 2026 | يومي |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 1410724 SH | 8 أغسطس، 2026 | يومي |
| NULV · Nushares ETF Trust | 0,19% | 34471 NS | 30 إبريل، 2026 | N-PORT |
| SGLC · RBB Fund, Inc. | 0,19% | 2753 NS | 31 مايو، 2026 | N-PORT |